Editorial Policy
Last updated: May, 2026
Our Commitment to Accuracy & Integrity
https://10peptides.com/ is dedicated to providing evidence‑based, scientifically accurate information about peptides, with a current focus on Retatrutide (referred to on this site as “Reta”). We follow strict editorial standards to ensure our content is trustworthy, transparent, and useful for researchers and informed readers.
1. Reliance on Peer‑Reviewed & Authoritative Sources
Every factual claim, clinical data point, safety consideration, or mechanism description on this site is supported by at least one of the following source types:
– Peer‑reviewed journal articles(e.g., New England Journal of Medicine, Nature, The Lancet, Diabetes Care, JCI Insight)
– Clinical trial registrations and results (e.g., ClinicalTrials.gov, EU Clinical Trials Register)
– Official regulatory documents (FDA, EMA, MHRA)
– Conference abstracts and proceedings from major scientific meetings (ADA, EASD, ENDO)
– Preclinical studies from established academic or research institutions
We do not rely on anecdotal reports, unverified forum posts, or commercial product listings as sources for clinical or safety information.
2. Direct Citations & Reference Lists
Each article, guide, or data summary includes:
– In‑text citations with superscript numbers or hyperlinks to the original source.
– A References section at the end of the page listing all cited sources in a clear, verifiable format (title, authors, journal, DOI, PMID, or direct URL to the clinical trial registry).
Example:
A Phase 2 trial reported a mean weight reduction of 22.8% after 48 weeks of Retatrutide treatment¹.
¹ Jastreboff AM, et al. *NEJM*. 2023;389(6):514-526. DOI: 10.1056/NEJMoa2301972.
3. Routine Content Updates & Expiration Notices
Peptide research evolves rapidly. To maintain accuracy:
– Quarterly reviews: All core pages (e.g., “Reta Complete Guide,” dosing, safety, mechanism) are reviewed every three months.
– Triggered updates: When a new Phase 3 trial result, regulatory action, or major safety warning is published, affected content is updated within 10 business days.
– Expiration notices: Pages older than 12 months that have not been updated will display a clear notice at the top:
> “This information was last reviewed on [DATE]. New clinical data may have been published since then. Please verify with primary sources.”
4. Correction & Retraction Policy
If we discover an error — whether factual, typographical, or interpretive — we will:
– Correct the error immediately and add a dated correction note at the bottom of the page.
– For significant scientific errors (e.g., incorrect dosing data, misreported side effect incidence), we will publish a retraction and correction as a standalone update notice linked from the original page.
Readers can report potential errors to: [ tenpeptides@gmail.com]
5. No Editorial Influence from Commercial Interests
We do not accept paid placements, sponsored posts, or affiliate links that influence our editorial content.
– Any product or service mention (e.g., laboratory suppliers, research tools) will be clearly labeled as “sponsored” or “affiliate” and will never alter the scientific accuracy of the page.
– We do not accept compensation from peptide sellers, compounding pharmacies, or clinical trial sponsors for favorable coverage.
6. Author & Reviewer Credentials
Content is written by researchers or science communicators with demonstrated knowledge of peptide biology, pharmacology, or clinical research.
– Each page lists the author if relevant and, if applicable, a medical/technical reviewer (e.g., pharmacologist, PhD in molecular biology).
– Author bios include relevant education or experience — but we never imply that any author is a licensed medical doctor unless that credential is explicitly stated.
7. Our Limitations (Clearly Stated)
This editorial policy does not make our content equivalent to professional medical advice. As stated in our Medical Disclaimer, all information is for research and educational use only. Readers should always consult a licensed physician before making any health decision.
Policy Review & Contact
This Editorial Policy is reviewed annually and updated as needed. For questions or to report a potential error, please contact:
Editorial Team
[tenpeptides@gmail.com]